Vaxcyte
Quarterly Financials
| Values in thousands | 2024-06-30 | 2024-03-31 | 2023-12-31 |
|---|---|---|---|
Revenue | $0 | $0 | $14,446 |
Gross Profit | -3,478 | -3,091 | 11,498 |
EBITDA | -152,981 | -113,473 | -177,853 |
EBIT | -156,459 | -116,564 | -180,801 |
Net Income | -128,703 | -95,020 | -180,801 |
Net Change In Cash | 0 | 0 | 14,446 |
Free Cash Flow | -166,768 | -171,196 | -185,879 |
Cash | 518,669 | 611,512 | 397,451 |
Basic Shares | 117,256 | 111,690 | 95,364 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -75,000 | -9,196 | -1,800 | -1,405 |
EBITDA | -464,885 | -214,289 | -98,277 | -87,805 |
EBIT | -468,041 | -223,485 | -100,077 | -89,210 |
Net Income | -402,266 | -239,640 | -100,084 | -87,819 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Cost of Revenue | -315,905 | 327,137 | ||
Free Cash Flow | -364,667 | -176,445 | -127,948 | -47,783 |
Cash | 397,451 | 834,657 | 68,985 | 386,200 |
Basic Shares | 97,157 | 64,877 | 51,922 | 51,071 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-09-30 | -$0.83 |
2024-06-30 | -$1.10 |
2024-03-31 | -$0.85 |
2023-12-31 | -$1.82 |
